2023 Form 5500 filing — Kowa Pharmaceuticals America, Inc. 401(K) Plan
Plain-English filing summary
According to public Form 5500 filings published through the U.S. Department of Labor (DOL) Employee Benefits Security Administration (EBSA) via the EFAST2 system, this is the 2023 Form 5500 filing (EFAST2 acknowledgement 20241014162959NAL0015294947001) for Kowa Pharmaceuticals America, Inc. 401(K) Plan, reported by Kowa Pharmaceuticals America, Inc. under EIN 20-1414357 and plan number 001. It reports 518 participants. Attached schedules in the loaded dataset include Schedule H (large plan financials), Schedule C (service provider compensation).
- EFAST2 acknowledgement
- 20241014162959NAL0015294947001
- Filing year
- 2023
- Form type
- 2
- Plan sponsor
- Kowa Pharmaceuticals America, Inc.
- EIN
- 20-1414357
- Plan number
- 001
- Location
- Montgomery, AL
- Participants
- 518
- Schedules available
- Schedule H, Schedule C
- Received date
- not reported in the loaded dataset
Reported financial snapshot (2023)
- Total assets (EOY)
- $35,587,390
- Net assets (EOY)
- $35,587,390
- Employer contributions
- $878,207
- Participant contributions
- $2,674,643
- Total income / additions
- $8,631,345
- Benefits paid
- $5,022,698
- Administrative expenses
- $14,330
- Total expenses
- $5,037,028
- Net increase / (decrease)
- $3,594,317
- Schedule source
- Schedule H
Reported service provider compensation (Schedule C)
| Provider | Service | Direct comp. | Indirect comp. |
|---|---|---|---|
| Murfee Meadows, Inc. | THIRD PARTY ADMINISTRATO | $0 | $16,567 |